3:59 PM
 | 
Sep 13, 2017
 |  BC Extra  |  Financial News

BridgeBio raises $135M round

BridgeBio Pharma (Palo Alto, Calif.) raised $135 million in an undisclosed venture round led by new investor Viking Global Investors and existing investor KKR.

New investors AIG, Aisling Capital, Cormorant Capital and Janus Funds also participated alongside existing investor Perceptive Advisors.

BridgeBio in-licenses rare genetic disease candidates from academia...

Read the full 236 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >